The groundbreaking promise of cell therapies to cure once-intractable diseases is increasingly colliding with the practical realities of complex and costly manufacturing, creating a significant barrier to widespread patient access. Innovative cell selection technologies are therefore becoming
A microscopic flaw in a single jet engine turbine blade, invisible to the naked eye, can ground an entire fleet, highlighting the immense pressure on material science and manufacturing to achieve absolute perfection. To address this critical challenge and accelerate innovation, America Makes has
The Promise and Peril of a Medical Revolution Cell and gene therapies stand at the forefront of a medical revolution, offering the potential to cure diseases once considered untreatable. Yet, this groundbreaking sector is caught in a profound paradox. While the science is delivering unprecedented
As India's specialty chemical sector stands at a critical juncture, balancing rapid industrial growth with an urgent need for sustainability and self-reliance, one company is stepping forward with a transformative agenda. Shivtek Spechemi Industries Ltd., the flagship of the Shiva Group of
A seismic shift is underway across the American industrial landscape, where an unprecedented surge of capital is fueling the rapid expansion of facilities designed to produce the next generation of life-saving medicines. This article analyzes the unprecedented surge in U.S. biomanufacturing
A quiet but monumental shift is reshaping the foundations of the pharmaceutical industry, driven by a convergence of unprecedented demand for new therapies and the fragile realities of a globally interconnected supply chain. Eli Lilly and Company is at the forefront of this transformation,
